In the Billon 2023 study, 50 mg/kg twice daily for 28 days increased succinate dehydrogenase-positive oxidative muscle fibers and raised OXPHOS complex protein levels
Longevity protocol: Dose: 0.5-1mg daily (lower end) Frequency: 3-5 times weekly Cycle: 8 weeks on, 4 weeks off, indefinite repetition Combine with: Overall health optimization (sleep, nutrition, exercise) Lower doses for longevity reduce cost and theoretical concerns about long-term copper peptide use while potentially maintaining meaningful benefits
BPC-157's gastric origin gives it natural relevance to gut research, and published work has characterised its activity in models of gastric ulceration, intestinal anastomosis, and inflammatory bowel injury
Active Ingredient Retatrutide 12.5mg + Cagrilintide 2.5mg Strength Tier Research-grade only Time to Results Not applicable (research use) Sun Sensitivity Not applicable research peptide Regulatory Status Research use only not for human consumption Cycling / Off Period Per study protocol not for human cycling Best For For licensed researchers and laboratory professionals studying GLP-1, GIP, glucagon, and amylin receptor pathways
